GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunic Inc (STU:10VA) » Definitions » Other Gross PPE

Immunic (STU:10VA) Other Gross PPE : €1.42 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Immunic Other Gross PPE?

Immunic's Other Gross PPE for the quarter that ended in Mar. 2024 was €1.42 Mil.

Immunic's quarterly Other Gross PPE increased from Sep. 2023 (€1.59 Mil) to Dec. 2023 (€1.62 Mil) but then declined from Dec. 2023 (€1.62 Mil) to Mar. 2024 (€1.42 Mil).

Immunic's annual Other Gross PPE increased from Dec. 2021 (€0.97 Mil) to Dec. 2022 (€1.74 Mil) but then declined from Dec. 2022 (€1.74 Mil) to Dec. 2023 (€1.62 Mil).


Immunic Other Gross PPE Historical Data

The historical data trend for Immunic's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunic Other Gross PPE Chart

Immunic Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.91 0.97 1.74 1.62

Immunic Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 1.98 1.59 1.62 1.42

Immunic Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Immunic (STU:10VA) Business Description

Traded in Other Exchanges
Address
1200 Avenue of the Americas, Suite 200, New York, NY, USA, 10036
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Immunic (STU:10VA) Headlines

No Headlines